Skip to main content

Advertisement

Log in

E-cadherin (CDH1) gene promoter polymorphism and the risk of colorectal cancer

A meta-analysis

  • Original Article
  • Published:
International Journal of Colorectal Disease Aims and scope Submit manuscript

Abstract

Objective

Published data on the relationship between E-cadherin (CDH1) gene promoter polymorphisms and colorectal cancer (CRC) risk are inconclusive. To derive a more precise estimation of the relationship, a meta-analysis was carried out.

Methods

In this meta-analysis, we evaluated reported studies of associations between polymorphisms of CDH1 gene promoter −160 C > A and −347 G > GA site, and CRC risk using fixed-effects model and random-effects model.

Results

We found decreased CRC risk among subjects carrying CDH1 −160AA (odds ratio [OR] = 0.86, 95 percent confidence interval [95% CI]: 0.75–0.98) and CA + AA (OR = 0.92, 95% CI: 0.87–0.98), using 4,652/4,428 cases/controls and 7,866/7,689 cases/controls from ten studies, respectively. We found a protective effect of the CDH1 −160CA + AA polymorphisms for CRC in distal site tumor population and population-based control in stratified analysis. We found a protective effect of the CDH1 −160AA and CA + AA polymorphisms for CRC in European and American population (OR = 0.87, 95% CI: 0.76–0.99 and OR = 0.91, 95% CI: 0.85–0.98, respectively). We observed that the CDH1 −347 G/GA + GA/GA carrier had an increased risk of CRC, the summary OR was 1.33 (95% CI: 1.08–1.62).

Conclusions

Data indicated that certain CDH1 gene promoter −160 C > A and −347 G > GA variants might affect the susceptibility of CRC. Recommendations for further studies include pooling of individual data to facilitate evaluation of multigenic effects and detailed analysis of effect modification by environmental and lifestyle factors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2010) Global cancer statistics. CA Cancer J Clin 61(2):69–90

    Article  Google Scholar 

  2. Jemal A, Siegel R, Xu J, Ward E (2010) Cancer statistics, 2010. CA Cancer J Clin 60(5):277–300

    Article  PubMed  Google Scholar 

  3. Chan AT, Giovannucci EL (2010) Primary prevention of colorectal cancer. Gastroenterology 138(6):2029–2043 e10

    Article  PubMed  CAS  Google Scholar 

  4. Ning Y, Wang L, Giovannucci EL (2010) A quantitative analysis of body mass index and colorectal cancer: findings from 56 observational studies. Obes Rev 11(1):19–30

    Article  PubMed  CAS  Google Scholar 

  5. Young TB, Wolf DA (1988) Case-control study of proximal and distal colon cancer and diet in Wisconsin. Int J Cancer 42(2):167–175

    Article  PubMed  CAS  Google Scholar 

  6. Norat T, Bingham S, Ferrari P, Slimani N, Jenab M, Mazuir M, Overvad K, Olsen A, Tjonneland A, Clavel F, Boutron-Ruault MC, Kesse E, Boeing H, Bergmann MM, Nieters A, Linseisen J, Trichopoulou A, Trichopoulos D, Tountas Y, Berrino F, Palli D, Panico S, Tumino R, Vineis P, Bueno-de-Mesquita HB, Peeters PH, Engeset D, Lund E, Skeie G, Ardanaz E, Gonzalez C, Navarro C, Quiros JR, Sanchez MJ, Berglund G, Mattisson I, Hallmans G, Palmqvist R, Day NE, Khaw KT, Key TJ, San Joaquin M, Hemon B, Saracci R, Kaaks R, Riboli E (2005) Meat, fish, and colorectal cancer risk: the European Prospective Investigation into cancer and nutrition. J Natl Cancer Inst 97(12):906–916

    Article  PubMed  Google Scholar 

  7. Cho E, Smith-Warner SA, Ritz J, van den Brandt PA, Colditz GA, Folsom AR, Freudenheim JL, Giovannucci E, Goldbohm RA, Graham S, Holmberg L, Kim DH, Malila N, Miller AB, Pietinen P, Rohan TE, Sellers TA, Speizer FE, Willett WC, Wolk A, Hunter DJ (2004) Alcohol intake and colorectal cancer: a pooled analysis of 8 cohort studies. Ann Intern Med 140(8):603–613

    PubMed  Google Scholar 

  8. Botteri E, Iodice S, Raimondi S, Maisonneuve P, Lowenfels AB (2008) Cigarette smoking and adenomatous polyps: a meta-analysis. Gastroenterology 134(2):388–395

    Article  PubMed  Google Scholar 

  9. Houlston RS, Webb E, Broderick P, Pittman AM, Di Bernardo MC, Lubbe S, Chandler I, Vijayakrishnan J, Sullivan K, Penegar S, Carvajal-Carmona L, Howarth K, Jaeger E, Spain SL, Walther A, Barclay E, Martin L, Gorman M, Domingo E, Teixeira AS, Kerr D, Cazier JB, Niittymaki I, Tuupanen S, Karhu A, Aaltonen LA, Tomlinson IP, Farrington SM, Tenesa A, Prendergast JG, Barnetson RA, Cetnarskyj R, Porteous ME, Pharoah PD, Koessler T, Hampe J, Buch S, Schafmayer C, Tepel J, Schreiber S, Volzke H, Chang-Claude J, Hoffmeister M, Brenner H, Zanke BW, Montpetit A, Hudson TJ, Gallinger S, Campbell H, Dunlop MG (2008) Meta-analysis of genome-wide association data identifies four new susceptibility loci for colorectal cancer. Nat Genet 40(12):1426–1435

    Article  PubMed  CAS  Google Scholar 

  10. Tomlinson I, Webb E, Carvajal-Carmona L, Broderick P, Kemp Z, Spain S, Penegar S, Chandler I, Gorman M, Wood W, Barclay E, Lubbe S, Martin L, Sellick G, Jaeger E, Hubner R, Wild R, Rowan A, Fielding S, Howarth K, Silver A, Atkin W, Muir K, Logan R, Kerr D, Johnstone E, Sieber O, Gray R, Thomas H, Peto J, Cazier JB, Houlston R (2007) A genome-wide association scan of tag SNPs identifies a susceptibility variant for colorectal cancer at 8q24.21. Nat Genet 39(8):984–988

    Article  PubMed  CAS  Google Scholar 

  11. Tomlinson IP, Webb E, Carvajal-Carmona L, Broderick P, Howarth K, Pittman AM, Spain S, Lubbe S, Walther A, Sullivan K, Jaeger E, Fielding S, Rowan A, Vijayakrishnan J, Domingo E, Chandler I, Kemp Z, Qureshi M, Farrington SM, Tenesa A, Prendergast JG, Barnetson RA, Penegar S, Barclay E, Wood W, Martin L, Gorman M, Thomas H, Peto J, Bishop DT, Gray R, Maher ER, Lucassen A, Kerr D, Evans DG, Schafmayer C, Buch S, Volzke H, Hampe J, Schreiber S, John U, Koessler T, Pharoah P, van Wezel T, Morreau H, Wijnen JT, Hopper JL, Southey MC, Giles GG, Severi G, Castellvi-Bel S, Ruiz-Ponte C, Carracedo A, Castells A, Forsti A, Hemminki K, Vodicka P, Naccarati A, Lipton L, Ho JW, Cheng KK, Sham PC, Luk J, Agundez JA, Ladero JM, de la Hoya M, Caldes T, Niittymaki I, Tuupanen S, Karhu A, Aaltonen L, Cazier JB, Campbell H, Dunlop MG, Houlston RS (2008) A genome-wide association study identifies colorectal cancer susceptibility loci on chromosomes 10p14 and 8q23.3. Nat Genet 40(5):623–630

    Article  PubMed  CAS  Google Scholar 

  12. Zanke BW, Greenwood CM, Rangrej J, Kustra R, Tenesa A, Farrington SM, Prendergast J, Olschwang S, Chiang T, Crowdy E, Ferretti V, Laflamme P, Sundararajan S, Roumy S, Olivier JF, Robidoux F, Sladek R, Montpetit A, Campbell P, Bezieau S, O’Shea AM, Zogopoulos G, Cotterchio M, Newcomb P, McLaughlin J, Younghusband B, Green R, Green J, Porteous ME, Campbell H, Blanche H, Sahbatou M, Tubacher E, Bonaiti-Pellie C, Buecher B, Riboli E, Kury S, Chanock SJ, Potter J, Thomas G, Gallinger S, Hudson TJ, Dunlop MG (2007) Genome-wide association scan identifies a colorectal cancer susceptibility locus on chromosome 8q24. Nat Genet 39(8):989–994

    Article  PubMed  CAS  Google Scholar 

  13. Niittymäki I, Tuupanen S, Li Y, Järvinen H, Mecklin J, Tomlinson I, Houlston R, Karhu A, Aaltonen L (2011) Systematic search for enhancer elements and somatic allelic imbalance at seven low-penetrance colorectal cancer predisposition loci. BMC Med Genet 12(23):1–6

    Google Scholar 

  14. Takeichi M (1991) Cadherin cell adhesion receptors as a morphogenetic regulator. Science 251(5000):1451–1455

    Article  PubMed  CAS  Google Scholar 

  15. van Roy F, Berx G (2008) The cell–cell adhesion molecule E-cadherin. Cell Mol Life Sci 65(23):3756–3788

    Article  PubMed  CAS  Google Scholar 

  16. Li LC, Chui RM, Sasaki M, Nakajima K, Perinchery G, Au HC, Nojima D, Carroll P, Dahiya R (2000) A single nucleotide polymorphism in the E-cadherin gene promoter alters transcriptional activities. Cancer Res 60(4):873–876

    PubMed  CAS  Google Scholar 

  17. Shin Y, Kim IJ, Kang HC, Park JH, Park HR, Park HW, Park MA, Lee JS, Yoon KA, Ku JL, Park JG (2004) The E-cadherin −347G->GA promoter polymorphism and its effect on transcriptional regulation. Carcinogenesis 25(6):895–899

    Article  PubMed  Google Scholar 

  18. Grunhage F, Jungck M, Lamberti C, Berg C, Becker U, Schulte-Witte H, Plassmann D, Rahner N, Aretz S, Friedrichs N, Buettner R, Sauerbruch T, Lammert F (2008) Association of familial colorectal cancer with variants in the E-cadherin (CDH1) and cyclin D1 (CCND1) genes. Int J Colorectal Dis 23(2):147–154

    Article  PubMed  Google Scholar 

  19. Pittman AM, Twiss P, Broderick P, Lubbe S, Chandler I, Penegar S, Houlston RS (2009) The CDH1-160C>A polymorphism is a risk factor for colorectal cancer. Int J Cancer 125(7):1622–1625

    Article  PubMed  CAS  Google Scholar 

  20. Cattaneo F, Venesio T, Molatore S, Russo A, Fiocca R, Frattini M, Scovassi AI, Ottini L, Bertario L, Ranzani GN (2006) Functional analysis and case-control study of -160C/A polymorphism in the E-cadherin gene promoter: association with cancer risk. Anticancer Res 26(6B):4627–4632

    PubMed  CAS  Google Scholar 

  21. de Lima JM, de Souza LG, da Silva ID, Forones NM (2009) E-cadherin and metalloproteinase-1 and −7 polymorphisms in colorectal cancer. Int J Biol Markers 24(2):99–106

    PubMed  Google Scholar 

  22. Porter TR, Richards FM, Houlston RS, Evans DG, Jankowski JA, Macdonald F, Norbury G, Payne SJ, Fisher SA, Tomlinson I, Maher ER (2002) Contribution of cyclin d1 (CCND1) and E-cadherin (CDH1) polymorphisms to familial and sporadic colorectal cancer. Oncogene 21(12):1928–1933

    Article  PubMed  CAS  Google Scholar 

  23. Shin Y, Kim IJ, Kang HC, Park JH, Park HW, Jang SG, Lee MR, Jeong SY, Chang HJ, Ku JL, Park JG (2004) A functional polymorphism (−347 G– > GA) in the E-cadherin gene is associated with colorectal cancer. Carcinogenesis 25(11):2173–2176

    Article  PubMed  CAS  Google Scholar 

  24. Tan XL, Nieters A, Kropp S, Hoffmeister M, Brenner H, Chang-Claude J (2008) The association of cyclin D1 G870A and E-cadherin C-160A polymorphisms with the risk of colorectal cancer in a case control study and meta-analysis. Int J Cancer 122(11):2573–2580

    Article  PubMed  CAS  Google Scholar 

  25. Wang Q, Gao C, Dai W, Zou X, Yang X (2010) Association of-160A/C Single Nucleotide Polymorphism in E-cadherin Gene Promoter Region with Colorectal Cancer in China. Progress in Modern Biomedicine 10(24):4621–4625

    CAS  Google Scholar 

  26. Zhu Z, Cong W, Wang A, Jia H, Jin X, He X, Zhu G (2008) Association of CDH1 polymorphism with tumorigenesis and progression of colorectal cancer and hepatocellular carcinoma. Chin J Clin Exp Pathol 24(5):533–536

    CAS  Google Scholar 

  27. Wang GY, Lu CQ, Zhang RM, Hu XH, Luo ZW (2008) The E-cadherin gene polymorphism 160 C- > A and cancer risk: A HuGE review and meta-analysis of 26 case-control studies. Am J Epidemiol 167(1):7–14

    Article  PubMed  Google Scholar 

  28. Zou XP, Dai WJ, Cao J (2009) CDH1 promoter polymorphism (−347 G– > GA) is a possible prognostic factor in sporadic colorectal cancer. World J Gastroenterol 15(42):5340–5345

    Article  PubMed  CAS  Google Scholar 

  29. Dai W, Yao Y, Cao J, Zou X (2010) Association of single nucleotide polymorphism in E-cadherin gene promoter region with colorectal cancer in a Chinese population. Prog Mod Biomed 10(9):1665–1668

    CAS  Google Scholar 

  30. Nakamura A, Shimazaki T, Kaneko K, Shibata M, Matsumura T, Nagai M, Makino R, Mitamura K (2002) Characterization of DNA polymorphisms in the E-cadherin gene (CDH1) promoter region. Mutat Res 502(1–2):19–24

    PubMed  CAS  Google Scholar 

  31. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7(3):177–188

    Article  PubMed  CAS  Google Scholar 

  32. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315(7109):629–634

    Article  PubMed  CAS  Google Scholar 

  33. Wang Y, Yang H, Li L, Wang H (2010) Glutathione S-transferase T1 gene deletion polymorphism and lung cancer risk in Chinese population: a meta-analysis. Cancer Epidemiol 34(5):593–597

    Article  PubMed  CAS  Google Scholar 

  34. Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50(4):1088–1101

    Article  PubMed  CAS  Google Scholar 

  35. Xu T, Li X, Wang W, Hu P, Du F (2009) Detection of publication bias in meta-analysis of dichotomous variable—Egger test and Begg test. J Evidence-Based Med 19(3):181–184

    Google Scholar 

  36. Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, Koskenvuo M, Pukkala E, Skytthe A, Hemminki K (2000) Environmental and heritable factors in the causation of cancer—analyses of cohorts of twins from Sweden, Denmark, Finland. N Engl J Med 343(2):78–85

    Article  PubMed  CAS  Google Scholar 

  37. Calvert PM, Frucht H (2002) The genetics of colorectal cancer. Ann Intern Med 137(7):603–612

    PubMed  CAS  Google Scholar 

  38. Dahabreh IJ, Linardou H, Bouzika P, Varvarigou V, Murray S (2010) TP53 Arg72Pro polymorphism and colorectal cancer risk: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev 19(7):1840–1847

    Article  PubMed  CAS  Google Scholar 

  39. Al-Moundhri MS, Al-Khanbashi M, Al-Kindi M, Al-Nabhani M, Burney IA, Al-Farsi A, Al-Bahrani B (2010) Association of E-cadherin (CDH1) gene polymorphisms and gastric cancer risk. World J Gastroenterol 16(27):3432–3436

    Article  PubMed  CAS  Google Scholar 

  40. Kiemeney LA, van Houwelingen KP, Bogaerts M, Witjes JA, Swinkels DW, den Heijer M, Franke B, Schalken JA, Verhaegh GW (2006) Polymorphisms in the E-cadherin (CDH1) gene promoter and the risk of bladder cancer. Eur J Cancer 42(18):3219–3227

    Article  PubMed  CAS  Google Scholar 

  41. Qiu LX, Li RT, Zhang JB, Zhong WZ, Bai JL, Liu BR, Zheng MH, Qian XP (2009) The E-cadherin (CDH1)–160 C/A polymorphism and prostate cancer risk: a meta-analysis. Eur J Hum Genet 17(2):244–249

    Article  PubMed  CAS  Google Scholar 

  42. Chien M, Chou L, Chung T, Lin C, Chou M, Weng M, Yang S, Chen M (2011) Effects of E-cadherin (CDH1) gene promoter polymorphisms on the risk and clinicopathologic development of oral cancer. Head Neck. doi:10.1002/hed.21746

  43. Chien M, Yeh K, Li Y, Hsieh Y, Lin C, Weng M, Kuo W, Yang S (2011) Effects of E-cadherin (CDH1) gene promoter polymorphisms on the risk and clinicopathological development of hepatocellular carcinoma. J Surg Oncol. doi:10.1002/jso.21929

  44. Zhang XF, Wang YM, Ge H, Cao YY, Chen ZF, Wen DG, Guo W, Wang N, Li Y, Zhang JH (2008) Association of CDH1 single nucleotide polymorphisms with susceptibility to esophageal squamous cell carcinomas and gastric cardia carcinomas. Dis Esophagus 21(1):21–29

    PubMed  Google Scholar 

  45. Li Y, Liang J, Kang S, Dong Z, Wang N, Xing H, Zhou R, Li X, Zhao X (2008) E-cadherin gene polymorphisms and haplotype associated with the occurrence of epithelial ovarian cancer in Chinese. Gynecol Oncol 108(2):409–414

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

We thank Dr. Jacqueline Miranda de Lima for collaboration and availability to share his papers for this present meta-analysis.

Conflicts of interest

No potential conflicts of interest are disclosed.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yadong Wang.

Additional information

Y. Wang and H. Yang contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wang, Y., Yang, H., Li, L. et al. E-cadherin (CDH1) gene promoter polymorphism and the risk of colorectal cancer. Int J Colorectal Dis 27, 151–158 (2012). https://doi.org/10.1007/s00384-011-1320-7

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00384-011-1320-7

Keywords

Navigation